STEPHEN P SQUINTO Insider Trading $ANCN Chemomab Therapeutics Ltd.
Get free email notifications about insider trading for STEPHEN P SQUINTO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN P SQUINTO. STEPHEN P SQUINTO is EVP & Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research & Devel in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research & Development in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research and Development in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec. VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP& Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP/Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Chemomab Therapeutics Ltd. ($ANCN) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in SpringWorks Therapeutics, Inc. ($SWTX) and Head of Research and Dev in Passage BIO, Inc. ($PASG).
STEPHEN P SQUINTO in Chemomab Therapeutics Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN P SQUINTO: Director
Holdings: 0 shares
Latest Transaction: Apr 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN P SQUINTO in Chemomab Therapeutics Ltd.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, BOLD, ANCN, PASG, SWTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2021 | ANCN | Chemomab Therapeut ... | SQUINTO STEPHEN P | Director | Option Exercise | A | 27.26 | 23,768 | 647,916 | 23,768 |
Page: 1